CTL Amedica secured Electronic Catalog (ECAT) government contract approval from the U.S. Defense Logistics Agency. The designation enables CTL Amedica to make available its full portfolio of spine products to veterans, military service members and other patients receiving care at U.S. Department of Defense (DOD) and U.S. Department of Veterans Affairs (VA) facilities.
ECAT was developed to streamline the Defense Logistics Agency’s business practices and expand its range of procurement options. ECAT also allows deploying units to rapidly acquire the full spectrum of products necessary to satisfy their requirements from many commercial sources.
CTL Amedica is the world’s exclusive provider of silicon nitride spine products. Silicon nitride spine products have demonstrated greater protein absorption and increased osseointegration, promote better bone growth, enhance osteogenic response and accelerate fusion. In addition, silicon nitride has been shown to deactivate several bacterial species and viral strains, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
“We’re proud to announce our ECAT government contract approval,” said CTL Amedica CEO Daniel Chon. “This will help make our full portfolio available to current and former service men and women and their families, who are receiving care through the DOD or VA. This includes our silicon nitride spine implants, whose unique properties help speed healing and enhance recovery. We’re grateful for the opportunity to make this technology more readily available.”
CTL Amedica secured Electronic Catalog (ECAT) government contract approval from the U.S. Defense Logistics Agency. The designation enables CTL Amedica to make available its full portfolio of spine products to veterans, military service members and other patients receiving care at U.S. Department of Defense (DOD) and U.S. Department of Veterans...
CTL Amedica secured Electronic Catalog (ECAT) government contract approval from the U.S. Defense Logistics Agency. The designation enables CTL Amedica to make available its full portfolio of spine products to veterans, military service members and other patients receiving care at U.S. Department of Defense (DOD) and U.S. Department of Veterans Affairs (VA) facilities.
ECAT was developed to streamline the Defense Logistics Agency’s business practices and expand its range of procurement options. ECAT also allows deploying units to rapidly acquire the full spectrum of products necessary to satisfy their requirements from many commercial sources.
CTL Amedica is the world’s exclusive provider of silicon nitride spine products. Silicon nitride spine products have demonstrated greater protein absorption and increased osseointegration, promote better bone growth, enhance osteogenic response and accelerate fusion. In addition, silicon nitride has been shown to deactivate several bacterial species and viral strains, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
“We’re proud to announce our ECAT government contract approval,” said CTL Amedica CEO Daniel Chon. “This will help make our full portfolio available to current and former service men and women and their families, who are receiving care through the DOD or VA. This includes our silicon nitride spine implants, whose unique properties help speed healing and enhance recovery. We’re grateful for the opportunity to make this technology more readily available.”
Copy to clipboard 
